article · BioMed Research International
The AS-AQ commonly used against Plasmodium allowed curing <i>S. mansoni</i> in coinfected children and increasing the Hb level. For the future, the randomized and multicentric clinical trials are needed for a better understanding of the effectiveness of AS-AQ against <i>Schistosoma spp</i>. The trial registration number was 3487183.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1155/2018/3487183
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
